2004
DOI: 10.1016/j.giec.2004.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology and pharmacokinetics of sedatives and analgesics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
95
0
7

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 94 publications
(102 citation statements)
references
References 93 publications
0
95
0
7
Order By: Relevance
“…Los fármacos implicados con mayor frecuencia en las IF fueron Hidrato de Cloral, Midazolam, y Vecuronio. Los 2 primeros son sedantes y el tercero miorelajante 6,[18][19][20] . La analgesia y sedación en UCIP es necesaria no sólo por razones humanitarias, sino que desde el punto de vista fisiopatológico, la supresión del dolor, frena la respuesta neuroendocrina inicialmente beneficiosa, pero inútil y perjudicial a muy corto plazo.…”
Section: Discussionunclassified
“…Los fármacos implicados con mayor frecuencia en las IF fueron Hidrato de Cloral, Midazolam, y Vecuronio. Los 2 primeros son sedantes y el tercero miorelajante 6,[18][19][20] . La analgesia y sedación en UCIP es necesaria no sólo por razones humanitarias, sino que desde el punto de vista fisiopatológico, la supresión del dolor, frena la respuesta neuroendocrina inicialmente beneficiosa, pero inútil y perjudicial a muy corto plazo.…”
Section: Discussionunclassified
“…The most commonly used agents, benzodiazepines, and opioids have some of these properties, but each has limitations [8]. Benzodiazepines are generally well tolerated and associated with improved patient satisfaction.…”
Section: Discussionmentioning
confidence: 99%
“…Propofol also provided significantly better patient cooperation than midazolam. 12,13 However, this agent occasionally decreases systemic vascular resistance, cardiac contractility, and ultimately cardiac output without a concomitant change in heart rate, and respiratory depression can also occur. 5,14,15 Recently, several studies have revealed most adverse events associated with propofol sedation were mild and often transient during advanced interventional endoscopic procedure.…”
Section: Discussionmentioning
confidence: 99%
“…5,14,15 Recently, several studies have revealed most adverse events associated with propofol sedation were mild and often transient during advanced interventional endoscopic procedure. 12,[16][17][18] A randomized study in Japan, which compared continuous propofol infusion with intermittent midazolam injection during ESD for EGC, found that propofol is a safe and effective sedative agent and that patients treated with propofol had a quicker recovery than those who were treated with midazolam. 3 In those studies, however, sedation was mostly targeted to a moderate level and did not monitor an accurate sedation level during the procedure.…”
Section: Discussionmentioning
confidence: 99%